222 related articles for article (PubMed ID: 2717642)
1. A monoclonal antibody (B72.3) to adenocarcinoma of the colon and related tumors.
Schlom J; Colcher D; Szpak CA; Johnston WW; Sugarbaker P; Carrasquillo JA; Reynolds JC; Larson SM
Prog Clin Biol Res; 1989; 288():63-72. PubMed ID: 2717642
[No Abstract] [Full Text] [Related]
2. Radioimmunoscintigraphy of human colon cancer xenografts in mice with radioiodinated monoclonal antibody B72.3.
Keenan AM; Colcher D; Larson SM; Schlom J
J Nucl Med; 1984 Nov; 25(11):1197-203. PubMed ID: 6333494
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for recurrent colorectal cancers with human monoclonal antibody SK-1.
Koda K; Glassy MC; McKnight ME; Yasutomi J; Saito N; Dan M; Nakajima N
Anticancer Res; 2001; 21(1B):621-7. PubMed ID: 11299816
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the colorectal antigen IOR C2.II.
Vázquez AM; Tormo B; Velandia A; Gómez CA; Alfonso M; Giscombe R; Ansotegui I; Jeddi-Tehrani M; Pérez R; Mellstedt H
Year Immunol; 1993; 7():137-45. PubMed ID: 7690506
[No Abstract] [Full Text] [Related]
5. Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A.
Liljefors M; Nilsson B; Hjelm Skog AL; Ragnhammar P; Mellstedt H; Frödin JE
Int J Cancer; 2003 Jul; 105(5):717-23. PubMed ID: 12740924
[TBL] [Abstract][Full Text] [Related]
6. Human monoclonal antibodies: a tool for cancer detection in vivo.
Ditzel HJ
APMIS Suppl; 1999; 94():5-42. PubMed ID: 10437609
[No Abstract] [Full Text] [Related]
7. [Comparative study of CEA antibody scan and computed tomography scan in the follow-up of patients with colorectal cancer].
García Vicente A; Soriano Castrejón A; González R; Rodado Marina S; Poblete García VM
Rev Esp Med Nucl; 2002; 21(5):349-55. PubMed ID: 12236910
[TBL] [Abstract][Full Text] [Related]
8. Potential clinical utility of monoclonal antibodies in the management of human carcinomas.
Schlom J; Weeks MO
Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739
[No Abstract] [Full Text] [Related]
9. 124I-HuCC49deltaCH2 for TAG-72 antigen-directed positron emission tomography (PET) imaging of LS174T colon adenocarcinoma tumor implants in xenograft mice: preliminary results.
Zou P; Povoski SP; Hall NC; Carlton MM; Hinkle GH; Xu RX; Mojzisik CM; Johnson MA; Knopp MV; Martin EW; Sun D
World J Surg Oncol; 2010 Aug; 8():65. PubMed ID: 20691066
[TBL] [Abstract][Full Text] [Related]
10. Development of monoclonal antibody imaging of metastatic prostatic carcinoma.
Meyers FJ; Denardo SJ; Macey D; White RD; Unger M
Prostate; 1989; 14(3):209-20. PubMed ID: 2471962
[TBL] [Abstract][Full Text] [Related]
11. [Radiopharmacokinetics of 131I-antibodies against colon cancer used in immunoscintigraphy in animal experiments].
Alexander SK; Fidler LM; Pugacov KK; Revazova ES; Avdeev GI
Radiobiol Radiother (Berl); 1988; 29(4):489-95. PubMed ID: 3186953
[No Abstract] [Full Text] [Related]
12. Human monoclonal antibodies.
Kan-Mitchell J; Mitchell MS
Prog Clin Biol Res; 1989; 288():85-94. PubMed ID: 2717643
[No Abstract] [Full Text] [Related]
13. A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma.
Magnani JL; Brockhaus M; Smith DF; Ginsburg V; Blaszczyk M; Mitchell KF; Steplewski Z; Koprowski H
Science; 1981 Apr; 212(4490):55-6. PubMed ID: 7209516
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody directed against colon cancer mucin has high specificity for malignancy.
Siddiki B; Ho JJ; Huang J; Byrd JC; Lau E; Yuan M; Kim YS
Int J Cancer; 1993 May; 54(3):467-74. PubMed ID: 7685327
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo perfusion of a tumor-containing colon with monoclonal antibody.
Sears HF; Herlyn D; Herlyn M; Grotzinger PJ; Steplewski Z; Gerhard W; Koprowski H
J Surg Res; 1981 Aug; 31(2):145-50. PubMed ID: 6790874
[No Abstract] [Full Text] [Related]
16. Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides.
Lindholm L; Holmgren J; Svennerholm L; Fredman P; Nilsson O; Persson B; Myrvold H; Lagergård T
Int Arch Allergy Appl Immunol; 1983; 71(2):178-81. PubMed ID: 6840874
[TBL] [Abstract][Full Text] [Related]
17. [Can monoclonal antibodies to a carcinoma-specific cell surface molecule prevent liver metastasis of human colorectal carcinoma and effectively treat already existing micrometastases?].
Burkart C; Porschen R
Z Gastroenterol; 1996 Jan; 34(1):41-2. PubMed ID: 8776175
[No Abstract] [Full Text] [Related]
18. Production of monoclonal antibodies using spleen cells from nude mice bearing human tumors.
Al Saati T; Blancher A; Calvas P; Neulat-Duga I; Delsol G
Ann Pathol; 1987; 7(1):1-8. PubMed ID: 3040026
[TBL] [Abstract][Full Text] [Related]
19. Estimates of radiation absorbed dose for intraperitoneally administered iodine-131 radiolabeled B72.3 monoclonal antibody in patients with peritoneal carcinomatoses.
Larson SM; Carrasquillo JA; Colcher DC; Yokoyama K; Reynolds JC; Bacharach SA; Raubitchek A; Pace L; Finn RD; Rotman M
J Nucl Med; 1991 Sep; 32(9):1661-7. PubMed ID: 1880565
[TBL] [Abstract][Full Text] [Related]
20. [Immunoscintigraphy with MAb B72.3 for preoperative detection of lymph node metastases of colorectal carcinoma].
Mörschel M; Bockisch A; Junginger T
Chirurg; 1995 May; 66(5):503-6. PubMed ID: 7607013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
